HomeInvestingIPOsKenvue (KVUE): A Johnson & Johnson (JNJ) Spinoff, Gains On IPO

Kenvue (KVUE): A Johnson & Johnson (JNJ) Spinoff, Gains On IPO

Kenvue (KVUE) gains over 17% fresh off their NYSE debut. Jenny Horne discusses this as KVUE is the consumer health business spin off of Johnson & Johnson (JNJ). KVUE started trading at $25.35, which is up 16% from the IPO price. She talks about how JNJ owns 1.72B KVUE shares. Tune in to find out more about the stock market today.

Market On Close

04 May 2023

ON AIR
education
1:00 pm
Your First Trade
replay
12:00 am
Fast Market
REPLAY
education
1:00 am
Your First Trade
REPLAY
1:30 am
Next Gen Investing
REPLAY
education
2:30 am
Your First Trade
REPLAY
3:00 am
Trading 360
REPLAY
4:00 am
Fast Market
REPLAY
5:00 am
Next Gen Investing
REPLAY
education
6:00 am
Your First Trade
REPLAY
6:30 am
Trading 360
REPLAY
7:30 am
Fast Market
REPLAY
8:30 am
Next Gen Investing
REPLAY
education
9:30 am
Your First Trade
REPLAY
10:00 am
Trading 360
REPLAY
11:00 am
Fast Market
REPLAY
12:00 pm
Next Gen Investing
REPLAY
ON AIR
education
1:00 pm
Your First Trade
REPLAY
1:30 pm
Trading 360
REPLAY
2:30 pm
Fast Market
REPLAY
3:30 pm
Next Gen Investing
REPLAY
education
4:30 pm
Your First Trade
REPLAY
5:00 pm
Trading 360
REPLAY
6:00 pm
Fast Market
REPLAY
7:00 pm
Next Gen Investing
REPLAY
education
8:00 pm
Your First Trade
REPLAY
8:30 pm
Trading 360
REPLAY
9:30 pm
Fast Market
REPLAY
10:30 pm
Next Gen Investing
REPLAY
education
11:30 pm
Your First Trade
REPLAY

Get Market Minute

Daily insights for every investor

FOLLOW US